2090 results
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
Xa Inhibitors - ... Rivaroxaban Oral Xa inhibitors ... overview of the dosing ... #Rivaroxaban #Dosing ... #Pharmacology
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
PDE5 inhibitors ... PDE5 inhibitors  ... PDE5 inhibitors ... #pharmacology #comparison ... #medications #dosing
Review of H2 Receptor Antagonists, Proton Pump Inhibitors, & Antacids.

#PPI #Antacids #H2Blocker #GERD #Reflux #Table #Pharmacology
Antagonists, Proton Pump Inhibitors ... Reflux #Table #Pharmacology ... #Dosing
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... Normal and Renal Dosing ... Stimulates Insulin, Inhibits ... #Renal #Dosing ... #Pharmacology #Management
Acyclovir - Pharmacology Summary

 • Mechanism of Action: Nucleoside analog - selectively inhibits viral replication of
Acyclovir - Pharmacology ... - selectively inhibits ... against CMV) • Dosing ... #Acyclovir #Pharmacology
NSAID Dosing in CKD
 • Carboxylic Acids: Salsalate, Choline Mg trisalicylate
 • Acetic Acids: Indomethacin, Tolmetin,
NSAID Dosing in ... Nabumetone • COX-2 Inhibitors ... Celecoxib #NSAID #Dosing ... #CKD #pharmacology
Allopurinol Pharmacology Summary

Xanthine oxidase inhibitor blocking the formation of new uric acid
Initiate 1-2 days prior to
Allopurinol Pharmacology ... Xanthine oxidase inhibitor ... chemotherapy Dosing ... #Allopurinol #Pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Phosphodiesterase-4 (PDE4) Inhibitor ... Eosinophils < 100 Dosing ... Roflumilast is a PDE4 inhibitor ... #Indications #Pharmacology
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
oral suspension DOSING ... ACE inhibitors, ... #Hyperkalemia #Pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Between Oral P2Y12 Inhibitors ... the timing and dosing ... .117.031164 #P2Y12 #Inhibitor ... ticagrelor #prasugrel #pharmacology